About this event
Watch our symposium from Tuesday, September 20th and explore one hour of Next-Level Liberation with FreeStyle Libre Ecosystem — One Tech Generation Ahead.
World-renowned diabetes experts will guide you through hot off the press clinical evidence of the FreeStyle Libre system to help you increase the impact of your diabetes care.
Afterwards, we will reveal unique innovative insights into our breakthrough technology that has been designed to allow even more individual decisions and to improve the health outcomes of your patients. During this session you will learn the latest must-knows about the Next-Level of Innovation in diabetes management, including FreeStyle Libre 3 — the world’s smallest1,2 and most accurate 14-day CGM3.
Curious for more? Our last session on Next-Level Connectivity will feature practical insights and clinical insights on the integrated smart pen solution with FreeStyle LibreLink — for a more efficient and assured decision making in the management of your diabetes patients.
Watch this insightful session online now.
1. Among patient-applied sensors.
2. Data on file, Abbott Diabetes Care, Inc.
3. Shridhara Alva, Timothy Bailey, Ronald Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, Hanquing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System with Advanced Algorithm in Pediatric and Adult Population With Diabetes.” [published online ahead of print September 19, 2020]. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820958754.
© 2022 Abbott. All rights reserved. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are property of their own respective owners.
ADC-64677 v1.0 10/22
Hosted by
-
External speaker
Prof. Magnus LoendahlE
Department of Endocrinology, Skane University Hospital, Lund (Sweden). Department of Clinical Sciences in Lund, Lund University, Lund (Sweden)
-
External speaker
Dr. Emma WilmotE
University Hospitals of Derby and Burton NHS Foundation Trust, University of Nottingham (United Kingdom)
-
External speaker
W. Scott Harper Divisional Vice President of R&D, Abbott Diabetes CareE
-
External speaker
Dr. Yvonne Winhofer-StöcklE
Medical University of Vienna (Austria) Dept. of Internal Medicine III, Division of Endocrinology and Metabolism
Abbott
At Abbott, we’re focused on making breakthrough technology accessible and approachable for all. Our sensing technology has revolutionized how people monitor glucose and provides doctors with more data for better informed treatment decisions
